Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Christine Didier, Cécile Demur, Fanny Grimal, Denis Jullien, Stéphane Manenti & Bernard Ducommun. (2012) Evaluation of checkpoint kinase targeting therapy in Acute Myeloid Leukemia with complex karyotype. Cancer Biology & Therapy 13:5, pages 307-313.
Read now
Read now
Articles from other publishers (29)
Feifei Wang, Odjo G. Gouttia, Ling Wang & Aimin Peng. (2022) PARP1 Upregulation in Recurrent Oral Cancer and Treatment Resistance. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Payal Gupta, R.C. Meena & Navin Kumar. (2020) Functional characterization of Candida glabrata ORF, CAGL0M02233g for its role in stress tolerance and virulence. Microbial Pathogenesis 149, pages 104469.
Crossref
Crossref
Jiyun Kwon, Suhee Lee, Yong-Nyun Kim & In Hye Lee. (2019) Deacetylation of CHK2 by SIRT1 protects cells from oxidative stress-dependent DNA damage response. Experimental & Molecular Medicine 51:3, pages 1-9.
Crossref
Crossref
Ummi Ammarah, Amit Kumar, Rajesh Pal, Naresh C. Bal & Gauri Misra. (2018) Identification of new inhibitors against human Great wall kinase using in silico approaches. Scientific Reports 8:1.
Crossref
Crossref
Ling Wang, Adam J. Mosel, Gregory G. Oakley & Aimin Peng. (2012) Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer. Molecular Cancer Therapeutics 11:11, pages 2401-2409.
Crossref
Crossref
Sonali S. Patil, Stanislaw R. Burzynski, Emilia Mrowczynski, Krzysztof Grela & Sridar V. Chittur. (2012) Phenylacetylglutaminate and Phenylacetate in Combination Upregulate VDUP1, Cause Cell Cycle Blockade and Apoptosis in U87 Glioblastoma Cells. Journal of Cancer Therapy 03:03, pages 192-200.
Crossref
Crossref
Jun Wu, Guozheng Lai, Feng Wan, Zhengzheng Xiao, Lingcheng Zeng, Xiongwei Wang, Fei Ye & Ting Lei. (2012) Knockdown of Checkpoint Kinase 1 Is Associated with the Increased Radiosensitivity of Glioblastoma Stem-Like Cells. The Tohoku Journal of Experimental Medicine 226:4, pages 267-274.
Crossref
Crossref
Monika Gupta, Sunil Gupta, Harish Dureja & Anil Kumar Madan. (2012) Superaugmented Eccentric Distance Sum Connectivity Indices: Novel Highly Discriminating Topological Descriptors for QSAR/QSPR. Chemical Biology & Drug Design 79:1, pages 38-52.
Crossref
Crossref
Susan Ashwell. 2012. DNA Repair in Cancer Therapy. DNA Repair in Cancer Therapy
211
234
.
George T. Lountos, Andrew G. Jobson, Joseph E. Tropea, Christopher R. Self, Guangtao Zhang, Yves Pommier, Robert H. Shoemaker & David S. Waugh. (2011) Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy. Journal of Structural Biology 176:3, pages 292-301.
Crossref
Crossref
Gilles Ferry, Aurélie Studeny, Céline Bossard, Philip M. Kubara, Denis Zeyer, Jean-Paul Renaud, Patrick Casara, Guillaume de Nanteuil, Michel Wierzbicki, Bruno Pfeiffer, Michelle Prudhomme, Stephane Leonce, Alain Pierré, Jean A. Boutin & Roy M. Golsteyn. (2011) Characterization of novel Checkpoint kinase 1 inhibitors by in vitro assays and in human cancer cells treated with topoisomerase inhibitors. Life Sciences 89:7-8, pages 259-268.
Crossref
Crossref
Loic P. Deleyrolle, Angus Harding, Kathleen Cato, Florian A. Siebzehnrubl, Maryam Rahman, Hassan Azari, Sarah Olson, Brian Gabrielli, Geoffrey Osborne, Angelo Vescovi & Brent A. Reynolds. (2011) Evidence for label-retaining tumour-initiating cells in human glioblastoma. Brain 134:5, pages 1331-1343.
Crossref
Crossref
S Zenvirt, N Kravchenko-Balasha & A Levitzki. (2010) Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents. Oncogene 29:46, pages 6149-6159.
Crossref
Crossref
Yun Dai & Steven Grant. (2010) New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network. Clinical Cancer Research 16:2, pages 376-383.
Crossref
Crossref
Yun DaiShuang ChenXin-Yan PeiJorge A. AlmenaraLora B. KramerCharis A. VendittiPaul Dent & Steven Grant. (2008) Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells. Blood 112:6, pages 2439-2449.
Crossref
Crossref
Susan Ashwell & Sonya Zabludoff. (2008) DNA Damage Detection and Repair Pathways—Recent Advances with Inhibitors of Checkpoint Kinases in Cancer Therapy. Clinical Cancer Research 14:13, pages 4032-4037.
Crossref
Crossref
Bradley A. Stohr & Elizabeth H. Blackburn. (2008) ATM Mediates Cytotoxicity of a Mutant Telomerase RNA in Human Cancer Cells. Cancer Research 68:13, pages 5309-5317.
Crossref
Crossref
Michael Goldstein, Wynand P. Roos & Bernd Kaina. (2008) Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: Contribution of DNA replication, transcription inhibition and Chk/p53 signaling. Toxicology and Applied Pharmacology 229:1, pages 20-32.
Crossref
Crossref
George T. Lountos, Joseph E. Tropea, Di Zhang, Andrew G. Jobson, Yves Pommier, Robert H. Shoemaker & David S. Waugh. (2008) Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor. Protein Science, pages NA-NA.
Crossref
Crossref
Deborah Wilsker & Fred Bunz. (2007) Loss of ataxia telangiectasia mutated– and Rad3-related function potentiates the effects of chemotherapeutic drugs on cancer cell survival. Molecular Cancer Therapeutics 6:4, pages 1406-1413.
Crossref
Crossref
Ana I. Robles, Mollie H. Wright, Bheru Gandhi, Steven S. Feis, Christin L. Hanigan, Adrian Wiestner & Lyuba Varticovski. (2006) Schedule-Dependent Synergy between the Heat Shock Protein 90 Inhibitor 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin and Doxorubicin Restores Apoptosis to p53-Mutant Lymphoma Cell Lines. Clinical Cancer Research 12:21, pages 6547-6556.
Crossref
Crossref
Korden Walter, Gabriele Warnecke, Richard Bowater, Wolfgang Deppert & Ella Kim. (2005) Tumor Suppressor p53 Binds with High Affinity to CTG·CAG Trinucleotide Repeats and Induces Topological Alterations in Mismatched Duplexes. Journal of Biological Chemistry 280:52, pages 42497-42507.
Crossref
Crossref
Catriona A. L. CLARKEPaul R. CLARKE. (2005) DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system. Biochemical Journal 388:2, pages 705-712.
Crossref
Crossref
Mikhail V. Blagosklonny. (2005) Overcoming limitations of natural anticancer drugs by combining with artificial agents. Trends in Pharmacological Sciences 26:2, pages 77-81.
Crossref
Crossref
Abdelhadi Rebbaa. (2005) Targeting senescence pathways to reverse drug resistance in cancer. Cancer Letters 219:1, pages 1-13.
Crossref
Crossref
Michal O. NowickiRafal FalinskiMateusz KoptyraArtur SlupianekTomasz StoklosaEwa GlocMargaret Nieborowska-SkorskaJanusz BlasiakTomasz Skorski. (2004) BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species–dependent DNA double-strand breaks. Blood 104:12, pages 3746-3753.
Crossref
Crossref
Jinwoo Ahn, Marshall Urist & Carol Prives. (2004) The Chk2 protein kinase. DNA Repair 3:8-9, pages 1039-1047.
Crossref
Crossref
Vasudha Sharma & Jetze J. Tepe. (2004) Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine. Bioorganic & Medicinal Chemistry Letters 14:16, pages 4319-4321.
Crossref
Crossref
Michael H Lam, Qinghua Liu, Stephen J Elledge & Jeffrey M Rosen. (2004) Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 6:1, pages 45-59.
Crossref
Crossref